scholarly article | Q13442814 |
P50 | author | Sara E. Mole | Q42563205 |
Varun Warrier | Q57644297 | ||
Mariana Vieira | Q86511095 | ||
P2093 | author name string | Mariana Vieira | |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 4 | |
P304 | page(s) | 1827-1830 | |
P577 | publication date | 2013-03-28 | |
P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
P1476 | title | Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses | |
P478 | volume | 1832 |
Q38391238 | A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry |
Q92122633 | A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs |
Q83226085 | A model of neuronal ceroid lipofuscinosis reveals a hypermorphic gain of function mechanism |
Q33626697 | A tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies. |
Q92907232 | ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis |
Q48469928 | Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations |
Q60045367 | Batten disease: biochemical and molecular characterization revealing novel PPT1 and TPP1 gene mutations in Indian patients |
Q36065476 | Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders |
Q34679086 | Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease). |
Q36010426 | Evaluation of disease progression in INCL by MR spectroscopy |
Q40038745 | Exacerbating and reversing lysosomal storage diseases: from yeast to humans |
Q35237718 | Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender |
Q83226104 | Fly model sheds light on brain disease |
Q92089380 | Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease |
Q42682614 | Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons. |
Q50109345 | Identification of two novel null variants in CLN8 by targeted next-generation sequencing: first report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants. |
Q37119594 | Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease |
Q27334931 | Loss of Cln3 function in the social amoeba Dictyostelium discoideum causes pleiotropic effects that are rescued by human CLN3 |
Q38808353 | MRI Brain Volume Measurements in Infantile Neuronal Ceroid Lipofuscinosis |
Q36647128 | Manifestation of neuronal ceroid lipofuscinosis in Australian Merino sheep: observations on altered behaviour and growth |
Q33918923 | Mesenchymal stem cells as cellular vectors for pediatric neurological disorders |
Q35588896 | Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis |
Q37496246 | Mutations in palmitoyl-protein thioesterase 1 alter exocytosis and endocytosis at synapses in Drosophila larvae |
Q27339580 | Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease) |
Q99556609 | Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities |
Q91114347 | Neuronal ceroid lipofuscinosis in a German Shorthaired Pointer associated with a previously reported CLN8 nonsense variant |
Q36685260 | Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation. |
Q64088327 | Next-Generation Sequencing Analysis Reveals Novel Pathogenic Variants in Four Chinese Siblings With Late-Infantile Neuronal Ceroid Lipofuscinosis |
Q35179770 | Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography |
Q58699413 | Novel in-frame deletion in MFSD8 gene revealed by trio whole exome sequencing in an Iranian affected with neuronal ceroid lipofuscinosis type 7: a case report |
Q35041354 | Partial genetic suppression of a loss-of-function mutant of the neuronal ceroid lipofuscinosis-associated protease TPP1 in Dictyostelium discoideum. |
Q34622488 | Progressive retinal degeneration and accumulation of autofluorescent lipopigments in Progranulin deficient mice |
Q47973239 | Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers |
Q36410273 | Suppression of agrin-22 production and synaptic dysfunction in Cln1 (-/-) mice |
Q35636176 | Sustained Neural Stem Cell-Based Intraocular Delivery of CNTF Attenuates Photoreceptor Loss in the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis |
Q38695394 | Synergistic effects of treating the spinal cord and brain in CLN1 disease. |
Q38261110 | Systemic diseases associated with retinal dystrophies |
Q38817664 | The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders. |
Q61446057 | Tracking sex-dependent differences in a mouse model of CLN6-Batten disease |
Q61443537 | Two cases of variant late infantile ceroid lipofuscinosis in Jordan |
Q35860759 | Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function |
Search more.